Article
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
The Journal of clinical endocrinology and metabolism - 1 May 2004
Lin-Su Karen, Zhou Ping, Arora Nimmi, Betensky Brian P, New Maria I, Wilson Robert C
Abstract excerpt
Apparent mineralocorticoid excess syndrome (AME) is an autosomal recessive disorder that results in low renin hypertension and other characteristic clinical features. Typical patients present with severe hypertension, hypokalemia, and undetectable aldosterone. Most patients also have low birth weight, failure to thrive, and nephrocalcinosis. The 11betahydroxysteroid dehydrogenase type 2 (11betaHSD2) defect is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
